Altimmune Inc
0.00 (0.0%)


Draw Mode:

Volume 50
Bid Price 4.37
Ask Price 4.49
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Altimmune Inc ALT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 4.37 04:33:12
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
1 50 - 3.83 - 23.49
Last Trade Time Type Quantity Stock Price Currency
04:29:06 50 $ 4.50 USD

Altimmune Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 215.35M 49.28M 42.96M $ -68.00k $ - -1.78 3.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 953.42k 10.30%

more financials information »

Altimmune News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ALT Message Board. Create One! See More Posts on ALT Message Board See More Message Board Posts

Historical ALT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.254.974.144.432,873,2160.122.82%
1 Month12.0012.1454.146.553,033,365-7.63-63.58%
3 Months14.7117.174.149.581,848,473-10.34-70.29%
6 Months12.6417.174.1410.581,589,493-8.27-65.43%
1 Year6.3023.493.8311.631,739,124-1.93-30.63%
3 Years3.0435.102.8013.241,840,3161.3343.75%
5 Years1.1936.250.24511.001,423,6343.18267.23%

Altimmune Description

Altimmune Inc is engaged on developing treatments for obesity and liver diseases. The Company's pipeline includes next generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.